Bioprocessing Alliance Inc, a new biologics drug development "think tank" meant to assist innovator companies with managing their third-party relationships, has set up shop in the 905 to serve the global market, with an "intergalactic headquarters" in Timmins.
Co-founder and director of corporate affairs Terry Cochrane says that in the past 10 years, innovator companies in the drug development field have moved away from constructing their own facilities to manufacture medications for clinical trials. The shift towards outsourcing in the industry has led to increased complexity in managing relationships with service providers. "
Our group has extensive experience managing these things from the service-provider side," Cochrane says. "We basically provide the handshake between the service providers and the knowledge companies."
Just launched on March 10, the Alliance is in "encouraging" talks with a long and growing list of potential clients, Cochrane says.
Writer: Edward Keenan
Source: Tom Cochrane, Director of Corporate Affairs, Bioprocessing Alliance Inc.